Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

T Cell and Interferon Expression in Tonsils After Sublingual Immunotherapy and/or Nasal Live Attenuated Influenza Vaccine

NCT01924208 is registered in ClinicalTrials.gov with Turku University Hospital as lead sponsor.

NCT NCT01924208
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01924208 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
T Cell and Interferon Expression in Tonsils After Sublingual Immunotherapy and/or Nasal Live Attenuated Influenza Vaccine
Lead sponsor
Turku University Hospital
Phase
Phase 3
Overall status
Unknown status
Start date
October 31, 2013
Completion date
September 30, 2016
Enrollment
180 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

healthy